← Eichor
Study identifier: NCT07249749 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Factor Associated With Mortality in the ICU

Condition: Critically Ill · Intensive Care (ICU) · Intensive Care Medicine  ·  Sponsor: Hospital Departamental de Villavicencio

PhaseN/A
Planned participants1000
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

ICU mortality indicates the severity of disease, healthcare quality, and the efficacy of interventions. The severity scores are tools to predict the risk of mortality in the ICU, and the APACHE II score is frequently used for this purpose. However, studies validating the score in Colombia are limited. There is uncertainty about the precision and discrimination capacity of the APACHE II score in a population that varies from the original, with varying diseases, and in a different timeline. The investigators determined to evaluate: 1. Evaluate the rate of mortality in the ICU by type of disease and type of admission. 2. The factors associated with mortality. 3. Validate the performance of the APACHE II score as a predictor of mortality.

This description comes directly from the study's public registry record.

Talk to the study team

Norton Perez Gutierrez, MD  ·  3112517471  ·  norton.perez@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital Departamental de VillavicencioVillavicencio, Meta Department, ColombiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07249749